GENE ONLINE|News &
Opinion
Blog

Tulip Chakraborty

WRITTEN BY Tulip Chakraborty

Potential Treatment for Osteogenesis Imperfecta Receives FDA’s “Rare Pediatric Disease Designation”
2020-09-27
Roche, AC Immune’s Alzheimer’s Drug Joins Long List of Trial Flops
2020-09-25
Roche’s Multifaceted Drug, Tecentriq Registers Mixed Results in Breast Cancer Patients
2020-09-22
Illumina Advances Talks to Acquire Healthcare Start-up Grail
2020-09-16
Exploring RNA Splicing as a Potential New Drug Avenue for Parkinson’s Disease
2020-09-16
Do You Need to Switch Antidepressants? Your Brainwaves Can Tell
2020-09-15
Korean Ginseng Gets Approved for a Functional Ingredient for Bone Health
2020-09-13
Vaccines Developing Can Catch Up SARS-CoV-2 Mutating?
2020-09-12
GAVRETO Grabs FDA Approval for Metastatic RET Fusion-Positive NSCLC
2020-09-08
Australian Pharma Bags Government Funding to Fight Duchenne Muscular Dystrophy
2020-09-06
Entering Late into the COVID-19 Vaccine Race, Could this Pharma Duo Measure up to Competition?
2020-09-06
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
Novartis’ Asciminib Shines in Chronic Myeloid Leukemia Trial
2020-08-28
Takeda to Sell its Japan Consumer Health Business to Blackstone for $2.3B
2020-08-25
Novartis’ Kesimpta Notches FDA Approval as Targeted B-cell Therapy for Patients with Relapsing MS
2020-08-23
1 … 3 4 5 6 7 8
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top